(Q41690303)

7 October 2017

1 reference

title

Schizophrenia, psychosis, and the basal ganglia (English)

1 reference

7 October 2017

1 reference

Geraldo Busatto Filho

1 reference

ORCID Public Data File 2021

author name string

Busatto GF

series ordinal

1

1 reference

7 October 2017

Kerwin RW

series ordinal

2

1 reference

7 October 2017

language of work or name

1 reference

1 December 1997

1 reference

Psychiatric Clinics of North America

7 October 2017

published in

1 reference

7 October 2017

volume

20

1 reference

7 October 2017

issue

4

1 reference

7 October 2017

page(s)

897-910

1 reference

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Schizophrenic auditory hallucinations are associated with increased regional cerebral blood flow during verbal memory activation in a study using single photon emission computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Parkinsonism in neuroleptic-naive schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Schizophrenia: a subcortical neurotransmitter imbalance syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Sydenham's chorea and schizophrenia: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Toward a brain map of auditory hallucinations.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Limbic/mesolimbic connections and the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Functional magnetic resonance imaging. A new technique with implications for psychology and psychiatry.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Left globus pallidus abnormality in never-medicated patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Single-photon emission computed tomography with 99mTc-exametazime in unmedicated schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Risk factors for spontaneous dyskinesia in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission Tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Functional and effective connectivity in neuroimaging: A synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Towards a neuropsychology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Neuropsychological assessment of monozygotic twins discordant for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

[3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Prenatal developmental disturbances in the limbic allocortex in schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

How do the neuropathological changes of schizophrenia relate to pre-existing neurotransmitter and aetiological hypotheses?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

The dopamine D4 receptor in schizophrenia: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Changes in caudate volume with neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Mechanisms of action of atypical antipsychotic drugs: a critical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Patterns of cerebral blood flow in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Medial temporal lobe structures in schizophrenia: relationship of size to duration of illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Central D2 receptors and negative symptoms of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

GABA and acute psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Levels of explanation--symptoms, neuropsychological deficit and morphological abnormalities in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Neuroleptic treatment and caudate plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Initial investigation of the left temporoparietal region in schizophrenia by 31P magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Post-mortem study of chronic schizophrenic brains

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Is the concept of frontal-subcortical dementia relevant to schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

The case of frontostriatal dysfunction in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Relationship between brain structure and function in disorders of the schizophrenic spectrum: single positron emission computerized tomography, computerized tomography and psychopathology of first episodes.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

The relationship of negative schizophrenia to parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Dopamine D4 receptors elevated in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

A functional neuroanatomy of hallucinations in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

An anatomy of schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

gamma-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

Widespread cerebral gray matter volume deficits in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970351-8

7 January 2021

10.1016/S0193-953X(05)70351-8

Identifiers

DOI

1 reference

7 October 2017

1 reference